Categories: Health

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025 after market close on Wednesday, February 25, 2026 at approximately 4:30 p.m. Eastern Time.

The Company will host a conference call to discuss these results the next day on Thursday, February 26, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

A live webcast of the call will be accessible by registering using the links below or through the Investor Relations section of the Company’s website at https://investors.parkdentalpartners.com. A replay of the webcast will be available on the website for a limited time following the call.

How to Participate:

About Park Dental Partners, Inc.
Park Dental Partners, Inc. (NASDAQ:PARK), and its subsidiaries, is a dental resource organization that has put patients first since establishment of its general dentistry group in 1972. The Company provides comprehensive business support services, including clinical team members, administrative personnel, facilities, and equipment, to its affiliated general and multi-specialty dental practices. The Company currently employs over 200 dentists across 88 practice locations in 3 states. The Company’s clinical support team consists of over 900 hygienists, dental assistants, and patient care coordinators that support affiliated dentists in operating their practices. Park Dental Partners is based in Roseville, Minnesota. For more information, please visit www.parkdentalpartners.com.



GlobeNews Wire

Recent Posts

Phemex Launches Prediction Market Powered by Polymarket, Introduces Month-Long Forecasting Championship

APIA, Samoa, April 23, 2026 /PRNewswire/ -- Phemex, a user-first global cryptocurrency exchange trusted by…

3 hours ago

Servier completes the acquisition of Day One Biopharmaceuticals

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric…

3 hours ago

Published Clinical Study Illustrates Benefits of Promentum Recover as Low-Dose Solution for Post Exercise Recovery

MOMENCE, Ill., April 23, 2026 /PRNewswire/ -- A recently published human clinical study demonstrates that…

3 hours ago

From South America to South India: A Young Life Stands Tall Again After Complex Robotic Spine Surgery

Chennai strengthens its position as a global hub for advanced spine care and medical value…

3 hours ago

Snail Games USA Releases New Developer Diary for Internally Developed Upcoming AAA Title For The Stars

April 23, 2026 17:05 ET  | Source: Snail, Inc. CULVER CITY, Calif., April 23, 2026…

5 hours ago

Parker Increases Quarterly Cash Dividend 11% to $2.00 per Share

April 23, 2026 17:00 ET  | Source: Parker-Hannifin Corporation CLEVELAND, April 23, 2026 (GLOBE NEWSWIRE)…

5 hours ago